Septerna NASDAQ:SEPN Septerna is a biotechnology company specializing in the discovery and development of novel therapeutics targeting G protein-coupled receptors (GPCRs). GPCRs are a large family of cell surface receptors that play crucial roles in various physiological processes, making them significant targets for drug development. However, traditional methods have faced challenges in effectively targeting these receptors. Septerna leverages advanced technologies to overcome these challenges, aiming to unlock new therapeutic opportunities for a range of diseases with unmet medical needs. The company's innovative approach allows for more efficient drug discovery processes, potentially leading to the development of safer and more effective medications.

Location: South San Francisco City, California, United States | Website: https://www.septerna.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing